Literature DB >> 20539035

Mechanism of cancer pain.

Brian L Schmidt1, Darryl T Hamamoto, Donald A Simone, George L Wilcox.   

Abstract

Ongoing and breakthrough pain is a primary concern for the cancer patient. Although the etiology of cancer pain remains unclear, animal models of cancer pain have allowed investigators to unravel some of the cancer-induced neuropathologic processes that occur in the region of tumor growth and in the dorsal horn of the spinal cord. Within the cancer microenvironment, cancer and immune cells produce and secrete mediators that activate and sensitize primary afferent nociceptors. Pursuant to these peripheral changes, nociceptive secondary neurons in spinal cord exhibit increased spontaneous activity and enhanced responsiveness to three modes of noxious stimulation: heat, cold, and mechanical stimuli. As our understanding of the peripheral and central mechanisms that underlie cancer pain improves, targeted analgesics for the cancer patient will likely follow.

Entities:  

Mesh:

Year:  2010        PMID: 20539035      PMCID: PMC2895277          DOI: 10.1124/mi.10.3.7

Source DB:  PubMed          Journal:  Mol Interv        ISSN: 1534-0384


  164 in total

1.  Nerve growth factor stimulates proliferation and survival of human breast cancer cells through two distinct signaling pathways.

Authors:  S Descamps; R A Toillon; E Adriaenssens; V Pawlowski; S M Cool; V Nurcombe; X Le Bourhis; B Boilly; J P Peyrat; H Hondermarck
Journal:  J Biol Chem       Date:  2001-02-28       Impact factor: 5.157

2.  Nerve growth factor and tyrosine kinase A receptor in oral squamous cell carcinoma: is there an association with perineural invasion?

Authors:  Antonia Kolokythas; Darren P Cox; Nusi Dekker; Brian L Schmidt
Journal:  J Oral Maxillofac Surg       Date:  2010-04-03       Impact factor: 1.895

3.  Topical capsaicin in humans: parallel loss of epidermal nerve fibers and pain sensation.

Authors:  M Nolano; D A Simone; G Wendelschafer-Crabb; T Johnson; E Hazen; W R Kennedy
Journal:  Pain       Date:  1999-05       Impact factor: 6.961

4.  Plasticity in the synthesis and storage of substance P and calcitonin gene-related peptide in primary afferent neurons during peripheral inflammation.

Authors:  M T Galeazza; M G Garry; H J Yost; K A Strait; K M Hargreaves; V S Seybold
Journal:  Neuroscience       Date:  1995-05       Impact factor: 3.590

5.  Antinociceptive synergy between delta(9)-tetrahydrocannabinol and opioids after oral administration.

Authors:  Diana L Cichewicz; Erin A McCarthy
Journal:  J Pharmacol Exp Ther       Date:  2003-03       Impact factor: 4.030

6.  Cannabinoid receptors CB1 and CB2: a characterization of expression and adenylate cyclase modulation within the immune system.

Authors:  A R Schatz; M Lee; R B Condie; J T Pulaski; N E Kaminski
Journal:  Toxicol Appl Pharmacol       Date:  1997-02       Impact factor: 4.219

Review 7.  Role of endogenous cannabinoids in synaptic signaling.

Authors:  Tamas F Freund; Istvan Katona; Daniele Piomelli
Journal:  Physiol Rev       Date:  2003-07       Impact factor: 37.312

Review 8.  Nerve growth factor and nociception.

Authors:  G R Lewin; L M Mendell
Journal:  Trends Neurosci       Date:  1993-09       Impact factor: 13.837

9.  Simultaneous reduction in cancer pain, bone destruction, and tumor growth by selective inhibition of cyclooxygenase-2.

Authors:  Mary Ann C Sabino; Joseph R Ghilardi; Joost L M Jongen; Cathy P Keyser; Nancy M Luger; David B Mach; Christopher M Peters; Scott D Rogers; Matthew J Schwei; Carmen de Felipe; Patrick W Mantyh
Journal:  Cancer Res       Date:  2002-12-15       Impact factor: 12.701

10.  Local injection of a selective endothelin-B receptor agonist inhibits endothelin-1-induced pain-like behavior and excitation of nociceptors in a naloxone-sensitive manner.

Authors:  Alla Khodorova; Moin U Fareed; Alexander Gokin; Gary R Strichartz; Gudarz Davar
Journal:  J Neurosci       Date:  2002-09-01       Impact factor: 6.167

View more
  50 in total

Review 1.  Acupuncture in the oncology setting: clinical trial update.

Authors:  Jillian L Capodice
Journal:  Curr Treat Options Oncol       Date:  2010-12

2.  Prophylactic treatment with the tricyclic antidepressant desipramine prevents development of paclitaxel-induced neuropathic pain through activation of endogenous analgesic systems.

Authors:  Liting Deng; Wan-Hung Lee; Zhili Xu; Alexandros Makriyannis; Andrea G Hohmann
Journal:  Pharmacol Res       Date:  2016-10-20       Impact factor: 7.658

3.  Surveying proteolytic processes in human cancer microenvironments by microdialysis and activity-based mass spectrometry.

Authors:  Markus Hardt; David K Lam; John C Dolan; Brian L Schmidt
Journal:  Proteomics Clin Appl       Date:  2011-12       Impact factor: 3.494

Review 4.  Head and neck cancer pain: systematic review of prevalence and associated factors.

Authors:  Tatiana V Macfarlane; Tanja Wirth; Sriyani Ranasinghe; Kim W Ah-See; Nick Renny; David Hurman
Journal:  J Oral Maxillofac Res       Date:  2012-04-01

Review 5.  Contribution of acidic extracellular microenvironment of cancer-colonized bone to bone pain.

Authors:  Toshiyuki Yoneda; Masahiro Hiasa; Yuki Nagata; Tatsuo Okui; Fletcher White
Journal:  Biochim Biophys Acta       Date:  2015-02-14

Review 6.  Pancreatic pain.

Authors:  Hana Nechutova; Petr Dite; Marketa Hermanova; Ivo Novotny; Arnost Martinek; Pavel Klvana; Bohumil Kianicka; Miroslav Soucek
Journal:  Wien Med Wochenschr       Date:  2014-03-12

7.  Preoperative Breast Pain Predicts Persistent Breast Pain and Disability After Breast Cancer Surgery.

Authors:  Dale J Langford; Brian Schmidt; Jon D Levine; Gary Abrams; Charles Elboim; Laura Esserman; Deborah Hamolsky; Judy Mastick; Steven M Paul; Bruce Cooper; Kord Kober; Marylin Dodd; Laura Dunn; Bradley Aouizerat; Christine Miaskowski
Journal:  J Pain Symptom Manage       Date:  2014-12-17       Impact factor: 3.612

Review 8.  Can Stopping Nerves, Stop Cancer?

Authors:  Jami L Saloman; Kathryn M Albers; Andrew D Rhim; Brian M Davis
Journal:  Trends Neurosci       Date:  2016-11-08       Impact factor: 13.837

9.  Preventive or late administration of anti-NGF therapy attenuates tumor-induced nerve sprouting, neuroma formation, and cancer pain.

Authors:  Juan Miguel Jimenez-Andrade; Joseph R Ghilardi; Gabriela Castañeda-Corral; Michael A Kuskowski; Patrick W Mantyh
Journal:  Pain       Date:  2011-09-09       Impact factor: 6.961

Review 10.  Biomarkers: symptoms, survivorship, and quality of life.

Authors:  Christine Miaskowski; Bradley E Aouizerat
Journal:  Semin Oncol Nurs       Date:  2012-05       Impact factor: 2.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.